AGP Executive Report
Last update: 6 hours agoPharma: Roche agreed to pay up to $1.1 billion for rights to a Rona Therapeutics obesity drug, extending its push into the fast-growing treatment market. Insurance: Swiss Re estimates hail caused CHF1.7 billion in damage, as extreme weather drives claims higher. Quantum technology: Infineon and Swiss startup ZuriQ expanded their partnership to develop scalable quantum chips. Flavours: Givaudan beat expectations for the first nine months, with fragrance leading growth. Manufacturing: Swiss family business Wagner is shutting down, putting 69 jobs at risk. Ride engineering: A fatal fall from a Bolliger & Mabillard coaster in Georgia prompted precautionary closures of similar rides across North America; the cause remains under investigation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.